Okapi Venture Capital

Okapi Venture Capital is a venture capital firm specializing in seed and early-stage investments in technology and life science sectors. The firm focuses on providing long-term capital and management support to emerging businesses, partnering with exceptionally talented entrepreneurs and operational executives to develop high-growth companies. Okapi Venture Capital manages Okapi Ventures I, LP, a fund chartered to invest in seed and early-stage information technology and life science companies along the Tech Coast, with a particular emphasis on Orange County startups. The firm's investment strategy targets capital-efficient businesses, typically investing between $750,000 and $3 million over the life of the company. Okapi Venture Capital has a track record of supporting companies like CrowdStrike, a software security company leveraging big data analytics, Connectifier, a SaaS company with a top-notch solution for discovering and connecting with candidates, Specright, a SaaS company offering an enterprise-ready solution for managing component specification data, ChromaCode, which redefines molecular testing through data science, and WhiteFox Defense Technologies, Inc., an emerging market leader in counter-drone technology. The firm's team comprises individuals with over 20 years of venture capital and technology executive experience, including Managing Directors Jeff Bocan and John Waller, Co-Founder and Managing Director Marc Averitt, and Co-Founder, Venture Partner, and Managing Director Sharon Stevenson, PhD, DVM. Okapi Venture Capital's investment focus includes sectors such as Biotech, Diagnostics, Internet, Healthcare IT & Services, Material Science, Medical Device, Semiconductor, Software, and Wireless. The firm is committed to fostering innovation and growth by partnering with entrepreneurs to bring their ideas to fruition and navigate the complexities of the startup landscape.